Clinical evaluation of a new, miniaturized biosensor for self- monitoring of blood glucose

Clinical Chemistry

Volumn 44, Issue 9, 1998, Pages 2056-2057

  Albertson, C ^a   Davis, C ^a   Ellison, J ^a   Chu, C ^a  

^a LifeScan Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FERRICYANIDE; GLUCOSE; GLUCOSE OXIDASE; REAGENT;

ADULT; AGED; BIOSENSOR; BLOOD GLUCOSE MONITORING; CONFERENCE PAPER; CONTROLLED STUDY; DIABETES MELLITUS; ELECTROCHEMICAL DETECTION; ELECTRONICS; GLUCOSE BLOOD LEVEL; GLUCOSE OXIDATION; HEMATOCRIT; HUMAN; MAJOR CLINICAL STUDY; REFERENCE VALUE; TEST STRIP;

EID: 0031753863     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/44.9.2056     Document Type: Conference Paper

References (5)

1. Diabetes Vital Statistics 1996. Alexandria, VA: American Diabetes Association, 1996:13.
2. 1996 Roper Starch Worldwide Diabetes Market Tracking Study. New York: Roper Starch, 1997:3.
3. Sacks D. Implications of the revised criteria for diagnosis and classification of diabetes mellitus [Editorial]. Clin Chem 1997;43:2230-2.
4. McAleer JF, Scott D, Hall G, Alvarez-Icaza M, Plotkin EV. United States patent 5,708,247, 1998.
5. Clarke WL, Cox D, Gonder-Frederick LA, Carter W, Pohl SL. Evaluating clinical accuracy of systems for self-monitoring of blood glucose. Diabetes Care 1987;10:622-8.